TECON(SZ:002100) Xin Lang Cai Jing·2025-10-22 06:13Core Viewpoint - TianKang Biological experienced a stock price decline of 2.05% on October 22, 2023, with a current price of 7.65 CNY per share and a total market capitalization of 10.44 billion CNY [1] Company Overview - TianKang Biological Co., Ltd. was established on December 28, 2000, and listed on December 26, 2006. The company is located in Urumqi, Xinjiang, and its main business includes the production and sale of biological vaccines for livestock and poultry, feed, and plant protein, as well as pig breeding, pig farming, slaughtering, and meat product sales [1] - The revenue composition of TianKang Biological includes: 32.20% from the pig farming industry chain, 27.51% from feed, 16.37% from protein and oil processing, 14.75% from corn, 5.44% from veterinary drugs, 3.40% from other income, 0.29% from supplementary income, and 0.04% from guarantee fees [1] Financial Performance - For the first half of 2025, TianKang Biological achieved an operating income of 8.847 billion CNY, representing a year-on-year growth of 10.68%. The net profit attributable to the parent company was 338 million CNY, with a year-on-year increase of 22.27% [2] - Since its A-share listing, TianKang Biological has distributed a total of 1.891 billion CNY in dividends, with 598 million CNY distributed in the last three years [3] Shareholder Information - As of September 30, 2023, TianKang Biological had 60,600 shareholders, a decrease of 3.42% from the previous period. The average circulating shares per person increased by 3.54% to 22,542 shares [2] - The top ten circulating shareholders include notable institutional investors such as Guotai Junan Zhongzheng Livestock Breeding ETF and Harvest Agricultural Industry Stock A, with significant increases in their holdings [3]